首页>
外国专利>
NOVEL CYCLIC PEPTIDE COMPOUND, METHOD FOR PRODUCING SAME, ANTI-INFECTIVE AGENT, ANTIBIOTIC-CONTAINING FRACTION, ANTIBIOTIC, METHOD FOR PRODUCING ANTIBIOTIC, ANTIBIOTIC-PRODUCING MICROORGANISM, AND ANTIBIOTIC PRODUCED BY SAME
NOVEL CYCLIC PEPTIDE COMPOUND, METHOD FOR PRODUCING SAME, ANTI-INFECTIVE AGENT, ANTIBIOTIC-CONTAINING FRACTION, ANTIBIOTIC, METHOD FOR PRODUCING ANTIBIOTIC, ANTIBIOTIC-PRODUCING MICROORGANISM, AND ANTIBIOTIC PRODUCED BY SAME
Provided are: a novel compound having a structuredifferent from that of existing drugs; a novel microorganismcapable of producing the novel compound; and further; a novelcompound effective to a multiple-drug-resistant bacterium. Toprovide a novel compound having a high therapeutic effect whichcan be expected to have a low hurdle for practical realizationby selecting an intended compound from many candidate compoundsbased not only on an antibacterial activity but also onevaluation including a therapeutic effect, a cyclic peptidecompound shown by the following formula (1) or apharmaceutically allowable salt thereof and a microorganismwith Accession No. NITE BP-870 or a microorganism mutatednaturally or artificially therefrom are provided.(In the formula (1) , R1 represents an acyl group having7 , 8, or 9 carbon atoms and optionally containing a substituentgroup; R2 represents a methyl group or a hydrogen atom; and R3represents an ethyl group or a methyl group.)92
展开▼
机译:提供:具有结构的新型化合物与现有药物不同;新微生物能够生产新型化合物;并进一步;一本小说对多重耐药细菌有效的化合物。至提供一种具有高治疗效果的新型化合物可以预期实现实际目标的障碍很小通过从许多候选化合物中选择所需化合物不仅基于抗菌活性,还基于评估包括疗效,环肽下式(1)所示的化合物或其可药用盐和微生物登记号为NITE BP-870或突变的微生物由此提供天然的或人工的。(在式(1)中,R 1表示具有7、8或9个碳原子,并可选包含取代基组; R 2表示甲基或氢原子;和R3代表乙基或甲基。)92
展开▼